What is Maternova?
Maternova operates as a mission-driven enterprise dedicated to addressing the systemic challenges of maternal and reproductive health. Since its inception in 2009, the company has established itself as a vital link in the medical supply chain, providing innovative diagnostic tools and life-saving devices to humanitarian organizations, ministries of health, and medical distributors. With a proven track record of impacting over 4.1 million lives across 65 countries, Maternova bridges the gap between cutting-edge medical technology and the regions that need it most, effectively reducing maternal mortality rates through strategic distribution and product development.
The company's market position is defined by its unique ability to navigate complex regulatory and logistical landscapes in developing economies. By focusing on high-impact, low-cost medical solutions, Maternova has created a sustainable model that aligns commercial viability with humanitarian outcomes, making it a cornerstone player in the global health equity movement.
How much funding has Maternova raised?
Maternova has raised a total of $23K across 1 funding round:
Debt
$23K
Debt (2021): $23K with participation from PPP
Key Investors in Maternova
PPP
Public-Private Partnership
What's next for Maternova?
With the recent infusion of capital, Maternova is poised to accelerate its growth trajectory by expanding its product portfolio and strengthening its distribution networks in emerging markets. The company is expected to prioritize the integration of advanced diagnostic technologies into its existing supply chain, further enhancing its capacity to serve ministries of health and international NGOs. As it transitions through this significant Series B/C stage, the focus will likely shift toward optimizing operational efficiencies and scaling its impact-driven business model to meet the rising demand for accessible neonatal and maternal care solutions globally. This strategic expansion will be critical in maintaining its competitive advantage while continuing to drive measurable improvements in global health outcomes.
See full Maternova company page
